MD Miodrag Manigoda

MD Miodrag Manigoda

Neurologist / Neurosonologist

Specific professional orientation:

A specialist in neurology with 17 years of specialized experience in both the public and private sectors, Dr. Manigoda received his education in neurology at leading domestic and foreign neurological institutions, such as the Clinic for Neurology at the Clinical Center of Serbia, the Clinic for Neurology at the Military Medical Academy, and the Clinic for Neurology at the Medical Faculty of the University of Heidelberg in Germany.

Dr. Manigoda’s areas of special expertise include headaches, multiple sclerosis, cerebrovascular diseases, and the application of ultrasound in neurology.

In addition to neurological examinations, doctor Miodrag Manigoda also performs Doppler ultrasound examinations of the carotid blood vessels and neck veins, transcranial Doppler (ultrasound examination of blood flow through the brain arteries), as well as highly sophisticated Doppler ultrasound methods of temporal arteries and transcranial ultrasonography of brain tissue (TCS), which are used in the diagnosis of certain headaches in older individuals and in patients suspected of having Parkinson’s disease.

As a neurologist, he has also been involved in clinical drug research.

Education:

1991-1998 Faculty of Medicine, University of Niš, Serbia

1999 Graduation exam on the topic “Height-based Diagnosis of Coma,” mentor Prof. Dr. Mirjana Živković

2000-2002 Postgraduate studies, Faculty of Medicine, University of East Sarajevo, RS, Bosnia and Herzegovina

2002-2006 Specialization in neurology, Faculty of Medicine, University of East Sarajevo and Faculty of Medicine, University of Belgrade

2003 Recipient of a TEMPUS project scholarship for a one-month study visit to the Department of Neurology and the Clinic for Neurology at the Medical Faculty, University of Heidelberg, Germany.

2007-2008 National School of Neuroangiology, Faculty of Medicine, University of Belgrade

Job:

1999-2007 Assistant at the Department of Pharmacology, Faculty of Medicine, University of East Sarajevo, RS, Bosnia and Herzegovina

2007-2023 Medigroup, Belgrade, Serbia – Neurologist

2014-2014 Medigroup-DZ “Dr. Ristic”, Belgrade, Serbia – Director

2023 – Special Hospital for Internal Medicine “Sirius Medical”, Belgrade – Neurologist

2023 – Puls Cardiology Center, Belgrade – Neurologist

1999-2002 Clinical Physician, Emergency Department, Clinical Hospital in Foča, RS, Bosnia and Herzegovina

1999-2002 Clinical Physician, Department of Neurology, Clinical Hospital in Foča, RS, Bosnia and Herzegovina

2002-2002 Neurology Resident, Department of Neurology, Clinical Hospital in Foča, RS, Bosnia and Herzegovina

2002-2006 Neurology Resident, Clinic for Neurology, Clinical Center of Serbia, Belgrade

2005-2007 On-duty Doctor in the Emergency Neurology Department, Clinical Center of Serbia, Belgrade

Memberships:

European Academy of Neurology

Medical Chamber of Serbia

Serbian Neurological Society

Serbian Headache Society

Publications:

  1. Acute sciatic neuropathy: “Saturday night palsy”Manigoda Miodrag; Dujmović-Bašuroski Irena; Trikić Rajko; Drulović Jelena. In: Srpski Arhiv za Celokupno Lekarstvo, Vol 133, Iss 1-2, Pp 58-61 (2005); Serbian Medical Society, 2005.
  2. Self-rated physical health predicts change in disability in multiple sclerosisDrulovic, J.; Riise, T.; Nortvedt, M.; Pekmezovic, T.; Manigoda, M.. In: MULTIPLE SCLEROSIS. 14(7):999-1002; Great Britain: SAGE Publications, 2008.
  3. Quality of life in patients with multiple sclerosis in Serbia Drulovic, J.; Pekmezovic, T.; Matejic, B.; Mesaros, S.; Manigoda, M.; Dujmovic, I.; Stojsavljevic, N.; Kocev, N.; Gavric-Kezic, M.; Nikic, P.. In: ACTA NEUROLOGICA SCANDINAVICA. 115(3):147-152; Denmark: BLACKWELL PUBLISHING LTD, 2007.
  4. The factors that influence the outcome of NEUROPAD test in patients with diabetes mellitus Manigoda, M.; Martinovic, J.; Manigoda, T.; Drobnjak, S.; Mitrovic, V.; Nikolovski, A.; Ristic, S.; Petkovic, S.. EUROPEAN JOURNAL OF NEUROLOGY; SEP 2010; 17; p557-p557,
  5. Prevalence and possible causes of restless legs syndrome in patients with systemic sclerosis Ostojic, P.; Stojic, B.; Janjic, S.; Jovic, T.; Manigoda, M.; Petkovic, S.; Damjanov, N.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; MAR-APR 2010; 28; 2; pS113-pS113,
  6. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials: Emmanuel Mignot, David Mayleben, Ingo Fietze, Damien Leger, Gary Zammit, Claudio L A Bassetti, Scott Pain, Dalma Seboek Kinter, Thomas Roth, on behalf of the investigators* Lancet Neurol 2022; 21: 125–39 (*Manigoda M. included in the List of Investigators)

 

Clinical studies:

Principal Investigator in the Study:

Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography study to assess the efficacy and safety of ACT-541468 in adult and elderly subjects with insomnia disorder (2019)

Co-Investigator in the following clinical studies:

Multi-center, double-blinded, randomized, phase 2 trial of ibudilast in relapsng-remitting mutiple sclerosis (2006-2007)

Multi-center, double-blind, placebo-controlled trial of cladribine tablets in multiple sclerosis (2006-2007)